"The U.S. Food and Drug Administration today expanded the approved use of Xgeva (denosumab) to treat adults and some adolescents with giant cell tumor of the bone (GCTB), a rare and usually non-cancerous tumor.
GCTB generally occurs in a"...
(Generic versions may still be available.)
DOSAGE AND ADMINISTRATION
One tablet (60 mg) twice daily for adults and pediatric patients 12 years and older.
USE OF DOSES IN EXCESS OF 60 MG B.I.D. IS NOT RECOMMENDED BECAUSE OF THE INCREASED POTENTIAL FOR QT INTERVAL PROLONGATIONS AND ADVERSE CARDIAC EVENTS. (See BOXED WARNING).USE OF TERFENADINE IN PATIENTS WITH SIGNIFICANT HEPATIC DYSFUNCTION AND IN PATIENTS TAKING KETOCONAZOLE, ITRACONAZOLE, CLARITHROMYCIN, ERYTHROMYCIN OR TROLEANDOMYCIN IS CONTRAINDICATED. (See CONTRAINDICATIONS, WARNINGS, and DRUG INTERACTIONS).
Removed from market 1998
60 mg tablets in bottles of 100.
60 mg tablets in bottles of 500.
Tablets are round, white, and debossed "SELDANE (terfenadine (removed from market 1998)) ". Store tablets at controlled room temperature (59-86°F) (15-30°C). Protect from exposure to temperatures above 104°F (40°C) and moisture.
Last reviewed on RxList: 12/8/2004
This monograph has been modified to include the generic and brand name in many instances.
Additional Seldane Information
Report Problems to the Food and Drug Administration
Find out what women really need.